Standard BioTools
LAB
98 hedge funds and large institutions have $182M invested in Standard BioTools in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 13 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 21
1% more funds holding
Funds holding: 97 → 98 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
26% less capital invested
Capital invested by funds: $246M → $182M (-$63.8M)
64% less call options, than puts
Call options by funds: $126K | Put options by funds: $349K
Top Buyers
| 1 |
LCS
Levin Capital Strategies
New York
|
+$7.25M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.51M |
| 3 |
Neuberger Berman Group
New York
|
+$3.03M |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$2.36M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$2.11M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIM
101
Bogle Investment Management
Newton Lower Falls,
Massachusetts
| – | -$367K | -40,696 | Closed |
|
102
AQR Capital Management
Greenwich,
Connecticut
| – | -$227K | -25,187 | Closed |
|
|
EGM
103
Engineers Gate Manager
New York
| – | -$161K | -17,877 | Closed |
|
|
CPC
104
Cookson Peirce & Co
Pittsburgh,
Pennsylvania
| – | -$123K | -13,575 | Closed |
|
105
Squarepoint
New York
| – | -$121K | -13,400 | Closed |
|
106
Teacher Retirement System of Texas
Austin,
Texas
| – | -$33K | -3,602 | Closed |
|
107
JP Morgan Chase
New York
| – | -$31K | -3,392 | Closed |
|
|
PCM
108
Prelude Capital Management
New York
| – | -$9K | -1,000 | Closed |
|
|
BCI
109
Brinker Capital Investments
Berwyn,
Pennsylvania
| – | +$9 | +1 | New |
|
110
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$230 | +25 | +2,500% |
|
LAB Hedge Fund Activity: Q3 2016 in Review
98 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2016, worth a combined $182M — down 26% from $246M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new LAB positions and 13 closed out — a net gain of 1 holder — while 34 added to existing stakes and 21 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $7.25M. The largest seller was Columbia Wanger Asset Management, exiting entirely with an estimated $16M sold.
- 98 institutional investors held Standard BioTools (LAB) as of Q3 2016, up from 97 in Q2 2016.
- Funds reported $182M of Standard BioTools stock for Q3 2016, down 26% quarter-over-quarter.
- 14 funds opened new Standard BioTools positions in Q3 2016 and 13 closed out, a net change of +1 holder.
- The largest Standard BioTools buyer in Q3 2016 was Levin Capital Strategies, an estimated $7.25M added.
- The largest Standard BioTools seller in Q3 2016 was Columbia Wanger Asset Management, an estimated $16M sold.
Based on aggregated 13F filings for Q3 2016.